Laura Pizzuti

4.0k total citations
96 papers, 1.7k citations indexed

About

Laura Pizzuti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Laura Pizzuti has authored 96 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Laura Pizzuti's work include HER2/EGFR in Cancer Research (23 papers), Cancer Treatment and Pharmacology (19 papers) and Advanced Breast Cancer Therapies (18 papers). Laura Pizzuti is often cited by papers focused on HER2/EGFR in Cancer Research (23 papers), Cancer Treatment and Pharmacology (19 papers) and Advanced Breast Cancer Therapies (18 papers). Laura Pizzuti collaborates with scholars based in Italy, Malaysia and United States. Laura Pizzuti's co-authors include Patrizia Vici, Maddalena Barba, Marcello Maugeri‐Saccà, Luigi Di Lauro, Teresa Gamucci, Domenico Sergi, Clara Natoli, Paolo Marchetti, Marcella Mottolese and Ruggero De Maria and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Laura Pizzuti

92 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Pizzuti Italy 23 906 454 410 333 206 96 1.7k
Luigi Di Lauro Italy 25 886 1.0× 398 0.9× 328 0.8× 307 0.9× 121 0.6× 113 1.7k
Johanna Louhimo Finland 29 770 0.8× 639 1.4× 353 0.9× 348 1.0× 179 0.9× 57 1.9k
Laura Zanotti Italy 27 527 0.6× 546 1.2× 352 0.9× 341 1.0× 150 0.7× 76 1.9k
Volker Möbus Germany 26 1.2k 1.3× 493 1.1× 587 1.4× 312 0.9× 276 1.3× 117 2.2k
Antje Lebrecht Germany 23 610 0.7× 407 0.9× 305 0.7× 147 0.4× 215 1.0× 58 1.4k
Hitoshi Niikura Japan 30 553 0.6× 673 1.5× 233 0.6× 288 0.9× 113 0.5× 97 2.5k
José Alejandro Pérez Fidalgo Spain 27 1.4k 1.6× 1.3k 2.8× 853 2.1× 569 1.7× 194 0.9× 136 2.9k
Dahish Ajarim Saudi Arabia 26 1.4k 1.5× 609 1.3× 527 1.3× 376 1.1× 421 2.0× 88 2.4k
Karin Leunen Belgium 33 997 1.1× 467 1.0× 501 1.2× 335 1.0× 121 0.6× 114 3.2k
Ioannis A. Voutsadakis Canada 27 1.2k 1.4× 914 2.0× 639 1.6× 474 1.4× 187 0.9× 161 2.3k

Countries citing papers authored by Laura Pizzuti

Since Specialization
Citations

This map shows the geographic impact of Laura Pizzuti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Pizzuti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Pizzuti more than expected).

Fields of papers citing papers by Laura Pizzuti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Pizzuti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Pizzuti. The network helps show where Laura Pizzuti may publish in the future.

Co-authorship network of co-authors of Laura Pizzuti

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Pizzuti. A scholar is included among the top collaborators of Laura Pizzuti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Pizzuti. Laura Pizzuti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiofalo, Benito, Giuseppe Sanguineti, Laura Pizzuti, et al.. (2024). Breast and cervical cancer in transgender men: literature review and a case report. Therapeutic Advances in Medical Oncology. 16. 12704202–12704202. 2 indexed citations
2.
Bon, Giulia, Eriseld Krasniqi, Manuela Porru, et al.. (2023). DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study. Neoplasia. 45. 100937–100937.
3.
Botticelli, Andrea, Agnese Fabbri, Michela Roberto, et al.. (2022). The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature. Frontiers in Oncology. 12. 797157–797157. 2 indexed citations
4.
Grassadonia, Antonino, Vincenzo Graziano, Laura Iezzi, et al.. (2021). Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting. Cells. 10(7). 1685–1685. 28 indexed citations
6.
Corte, Luigi Della, Pierluigi Giampaolino, Gabriele Saccone, et al.. (2019). A case of 20-week abortion in a rare communicating rudimentary horn of a misinterpreted unicornuate uterus, incorrectly diagnosed as bicornuate: A serious hazard!. European Journal of Obstetrics & Gynecology and Reproductive Biology. 235. 133–135. 3 indexed citations
7.
Botticelli, Andrea, Bruna Cerbelli, Luana Lionetto, et al.. (2018). The key role of kynurenine in antiPD-1 failure. Open Repository and Bibliography (University of Liège). 1 indexed citations
8.
Ercolani, Cristiana, Anna Di Benedetto, Irene Terrenato, et al.. (2017). Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy. Cancer Biology & Therapy. 18(5). 339–346. 15 indexed citations
9.
Barba, Maddalena, Patrizia Vici, Laura Pizzuti, et al.. (2017). Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer. BMC Cancer. 17(1). 101–101. 7 indexed citations
11.
Lauro, Luigi Di, Laura Pizzuti, Maddalena Barba, et al.. (2015). Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study. Journal of Experimental & Clinical Cancer Research. 34(1). 26–26. 15 indexed citations
12.
Camera, Luigi, Raffaele Liuzzi, Massimo Imbriaco, et al.. (2015). Balancing Radiation and Contrast Media Dose in Single-Pass Abdominal Multidetector CT. Academic Radiology. 22(11). 1419–1426. 3 indexed citations
13.
Pizzuti, Laura, Patrizia Vici, Luigi Di Lauro, et al.. (2015). Metformin and breast cancer: Basic knowledge in clinical context. Cancer Treatment Reviews. 41(5). 441–447. 13 indexed citations
14.
Gamucci, Teresa, Andrea Michelotti, Laura Pizzuti, et al.. (2014). Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study. Journal of Cancer. 5(5). 320–327. 43 indexed citations
15.
Vici, Patrizia, Laura Pizzuti, Teresa Gamucci, et al.. (2014). Non-Pegylated Liposomal Doxorubicin-Cyclophosphamide in Sequential Regimens with Taxanes as Neoadjuvant Chemotherapy in Breast Cancer Patients. Journal of Cancer. 5(6). 398–405. 6 indexed citations
16.
Lauro, Luigi Di, Patrizia Vici, Silverio Tomao, et al.. (2013). Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer. Gastric Cancer. 17(4). 718–724. 17 indexed citations
17.
Barba, Maddalena, Laura Pizzuti, Domenico Sergi, et al.. (2013). Hot flushes in women with breast cancer: state of the art and future perspectives. Expert Review of Anticancer Therapy. 14(2). 185–198. 4 indexed citations
18.
Vici, Patrizia, Giuseppe Colucci, Francesco Giotta, et al.. (2011). A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study. Journal of Experimental & Clinical Cancer Research. 30(1). 39–39. 18 indexed citations
20.
Pace, Leonardo, Emanuele Nicolai, Domenico D’Amico, et al.. (2010). Determinants of Physiologic 18F-FDG Uptake in Brown Adipose Tissue in Sequential PET/CT Examinations. Molecular Imaging and Biology. 13(5). 1029–1035. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026